BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26734995)

  • 1. HDAC inhibitors suppress c-Jun/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells.
    He W; Wu Y; Tang X; Xia Y; He G; Min Z; Li C; Xiong S; Shi Z; Lu Y; Yuan Z
    Oncotarget; 2016 Feb; 7(6):6727-47. PubMed ID: 26734995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase 6 promotes growth of glioblastoma through the MKK7/JNK/c-Jun signaling pathway.
    Huang Z; Xia Y; Hu K; Zeng S; Wu L; Liu S; Zhi C; Lai M; Chen D; Xie L; Yuan Z
    J Neurochem; 2020 Jan; 152(2):221-234. PubMed ID: 31390677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MKK7 transcription positively or negatively regulated by SP1 and KLF5 depends on HDAC4 activity in glioma.
    Wang Y; Xia Y; Hu K; Zeng M; Zhi C; Lai M; Wu L; Liu S; Zeng S; Huang Z; Ma S; Yuan Z
    Int J Cancer; 2019 Nov; 145(9):2496-2508. PubMed ID: 30963560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.
    Vial E; Marshall CJ
    J Cell Sci; 2003 Dec; 116(Pt 24):4957-63. PubMed ID: 14625389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells.
    Kimura R; Ishikawa C; Rokkaku T; Janknecht R; Mori N
    Biochim Biophys Acta; 2011 Aug; 1813(8):1543-53. PubMed ID: 21640141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway.
    Hoffmann E; Ashouri J; Wolter S; Doerrie A; Dittrich-Breiholz O; Schneider H; Wagner EF; Troppmair J; Mackman N; Kracht M
    J Biol Chem; 2008 May; 283(18):12120-8. PubMed ID: 18281687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation.
    Cook SJ; Aziz N; McMahon M
    Mol Cell Biol; 1999 Jan; 19(1):330-41. PubMed ID: 9858557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEP-induced fra-1 expression correlates with a distinct activation of AP-1-dependent gene transcription in the lung.
    Zhang Q; Kleeberger SR; Reddy SP
    Am J Physiol Lung Cell Mol Physiol; 2004 Feb; 286(2):L427-36. PubMed ID: 14565943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes.
    Wang X; Sonenshein GE
    J Virol; 2005 Jan; 79(1):95-105. PubMed ID: 15596805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A JNK-independent signaling pathway regulates TNF alpha-stimulated, c-Jun-driven FRA-1 protooncogene transcription in pulmonary epithelial cells.
    Adiseshaiah P; Kalvakolanu DV; Reddy SP
    J Immunol; 2006 Nov; 177(10):7193-202. PubMed ID: 17082637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Jun-NH2 terminal kinase (JNK)-mediates AP-1 activation by thioredoxin: phosphorylation of cJun, JunB, and Fra-1.
    Das KC; Muniyappa H
    Mol Cell Biochem; 2010 Apr; 337(1-2):53-63. PubMed ID: 19859790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5'-Nitro-indirubinoxime inhibits epidermal growth factor- and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1.
    Khanal P; Choi HK; Namgoong GM; Ahn SG; Yoon JH; Sohn H; Choi HS
    Mol Carcinog; 2011 Dec; 50(12):961-71. PubMed ID: 21400615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
    Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
    Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
    Eriksson M; Taskinen M; Leppä S
    J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.
    Cui J; Wang Q; Wang J; Lv M; Zhu N; Li Y; Feng J; Shen B; Zhang J
    Mol Cancer Ther; 2009 Dec; 8(12):3214-22. PubMed ID: 19996270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of signaling through SEK1 and MKK7 yields differential responses in hypoxic colon cancer cells treated with oxaliplatin.
    Vasilevskaya IA; Selvakumaran M; O'Dwyer PJ
    Mol Pharmacol; 2008 Jul; 74(1):246-54. PubMed ID: 18436711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc.
    Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-terminal kinase pathway.
    Lee SI; Boyle DL; Berdeja A; Firestein GS
    Arthritis Res Ther; 2012 Feb; 14(1):R38. PubMed ID: 22353730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.